BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24285818)

  • 1. Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.
    Hur YG; Crampin AC; Chisambo C; Kanyika J; Houben R; Ndhlovu R; Mzembe T; Lalor MK; Saul J; Branson K; Stanley C; Ngwira B; French N; Ottenhoff TH; Dockrell HM; Gorak-Stolinska P
    Clin Vaccine Immunol; 2014 Feb; 21(2):133-42. PubMed ID: 24285818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    J Infect; 2017 Aug; 75(2):132-145. PubMed ID: 28483404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.
    Hur YG; Gorak-Stolinska P; Ben-Smith A; Lalor MK; Chaguluka S; Dacombe R; Doherty TM; Ottenhoff TH; Dockrell HM; Crampin AC
    PLoS One; 2013; 8(11):e79742. PubMed ID: 24260295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to defined antigens of Mycobacterium bovis in cattle experimentally infected with Mycobacterium kansasii.
    Waters WR; Palmer MV; Thacker TC; Payeur JB; Harris NB; Minion FC; Greenwald R; Esfandiari J; Andersen P; McNair J; Pollock JM; Lyashchenko KP
    Clin Vaccine Immunol; 2006 Jun; 13(6):611-9. PubMed ID: 16760317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant ESAT-6:CFP-10 fusion protein for differentiation of infections of cattle by Mycobacterium bovis and by M. avium subsp. avium and M. avium subsp. paratuberculosis.
    Waters WR; Nonnecke BJ; Palmer MV; Robbe-Austermann S; Bannantine JP; Stabel JR; Whipple DL; Payeur JB; Estes DM; Pitzer JE; Minion FC
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):729-35. PubMed ID: 15242948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii.
    Arend SM; van Meijgaarden KE; de Boer K; de Palou EC; van Soolingen D; Ottenhoff TH; van Dissel JT
    J Infect Dis; 2002 Dec; 186(12):1797-807. PubMed ID: 12447766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study.
    Augustynowicz-Kopeć E; Siemion-Szcześniak I; Zabost A; Wyrostkiewicz D; Filipczak D; Oniszh K; Gawryluk D; Radzikowska E; Korzybski D; Szturmowicz M
    Pol J Microbiol; 2019; 68(1):15-19. PubMed ID: 31050249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
    Black GF; Weir RE; Chaguluka SD; Warndorff D; Crampin AC; Mwaungulu L; Sichali L; Floyd S; Bliss L; Jarman E; Donovan L; Andersen P; Britton W; Hewinson G; Huygen K; Paulsen J; Singh M; Prestidge R; Fine PE; Dockrell HM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):602-11. PubMed ID: 12853392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens.
    Kellar KL; Gehrke J; Weis SE; Mahmutovic-Mayhew A; Davila B; Zajdowicz MJ; Scarborough R; LoBue PA; Lardizabal AA; Daley CL; Reves RR; Bernardo J; Campbell BH; Whitworth WC; Mazurek GH
    PLoS One; 2011; 6(11):e26545. PubMed ID: 22132075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.
    Chiappini E; Della Bella C; Bonsignori F; Sollai S; Amedei A; Galli L; Niccolai E; Del Prete G; Singh M; D'Elios MM; de Martino M
    PLoS One; 2012; 7(9):e46041. PubMed ID: 23029377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis.
    Singh SB; Biswas D; Rawat J; Sindhwani G; Patras A; Devrani S; Sarkar P; Mitra S; Gupta SK
    Tuberculosis (Edinb); 2013 Nov; 93(6):618-24. PubMed ID: 24011630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong purified protein derivative responses are associated with poor mycobacterium inhibition in latent TB.
    Kang JS; Cherian A; Gan SH; Lee TH; Lee KC; Chee CB; Doherty TM; Wang YT; Seah GT
    Eur Respir J; 2010 Aug; 36(2):348-54. PubMed ID: 19996195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children.
    Connell TG; Curtis N; Ranganathan SC; Buttery JP
    Thorax; 2006 Jul; 61(7):616-20. PubMed ID: 16601088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific Host Signatures for the Detection of Tuberculosis Infection in Children in a Low TB Incidence Country.
    Dreesman A; Corbière V; Libin M; Racapé J; Collart P; Singh M; Locht C; Mascart F; Dirix V
    Front Immunol; 2021; 12():575519. PubMed ID: 33790886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey.
    Sato R; Nagai H; Matsui H; Kawabe Y; Takeda K; Kawashima M; Suzuki J; Ohshima N; Masuda K; Yamane A; Tamura A; Akagawa S; Ohta K
    J Infect; 2016 Jun; 72(6):706-712. PubMed ID: 27025204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.